Genetics Study of In-stent Restenosis
NCT01670396 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2012-08-22
Summary
The investigators hypothesized that genetic variants of G protein influence the development of restenosis and clinical outcome of patients receiving drug-eluting stents (DES).
Conditions
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2012-08-31
- Completion
- 2012-09-30
Countries
- China
Study Locations
More Related Trials
-
Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
NCT00369356 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dexamethasone-Eluting Stent in Acute Coronary Syndrome to Prevent Restenosis
NCT00190099 ·Status: COMPLETED ·Phase: PHASE4
-
Optimal Stent Deployment Strategy of Contemporary Stents
NCT05292651 ·Status: RECRUITING ·Phase: NA
-
Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis(CREST)
NCT05606367 ·Status: UNKNOWN ·Phase: NA
-
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
NCT06919562 ·Status: RECRUITING
-
Optical Coherence TomOgraphy Assessment of the Drug-Eluting Stent
NCT01012583 ·Status: UNKNOWN
-
Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation
NCT01835301 ·Status: UNKNOWN
-
Drug Coated Balloon Versus Stenting in Patients With Symptomatic Vertebral Artery Stenosis：an Observational Clinical Study
NCT03311360 ·Status: COMPLETED
-
Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR
NCT04767022 ·Status: COMPLETED ·Phase: NA
-
The 3D Stent Study
NCT06898021 ·Status: RECRUITING
-
Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis
NCT00811772 ·Status: COMPLETED ·Phase: NA
-
Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions
NCT05200637 ·Status: UNKNOWN ·Phase: NA
-
OCT Based Edge and In-stent Vascular Response After Cordimax Stent in patIents With NSTE-ACS
NCT02868203 ·Status: UNKNOWN ·Phase: PHASE4
-
Angina After PCI: a Systems Medicine Study
NCT06854302 ·Status: ENROLLING_BY_INVITATION
-
Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis
NCT00493597 ·Status: COMPLETED
-
Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis
NCT01466634 ·Status: COMPLETED
-
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
NCT00611910 ·Status: COMPLETED ·Phase: PHASE4
-
the Effect of Prolonged Inflation Time During Stents Deployment for ST-elevation Myocardial Infarction
NCT03199014 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Study of the Impact of Drug Eluting Stents
NCT00487604 ·Status: UNKNOWN
-
ProStent Coronary Drug-Eluting Stent
NCT00887211 ·Status: UNKNOWN ·Phase: NA
-
A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)
NCT00322569 ·Status: COMPLETED ·Phase: PHASE3
-
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
NCT05544864 ·Status: RECRUITING ·Phase: NA
-
Vascular Implant Safety and Efficacy Study
NCT03263858 ·Status: COMPLETED ·Phase: NA
-
Progenitor Cells Role in Restenosis and Atherosclerosis
NCT01575431 ·Status: COMPLETED
-
In-stent Restenosis in Patients With Patent Previous Bare Metal Stent
NCT01296399 ·Status: COMPLETED